ERIKA

This brand name is authorized in Ecuador

Active ingredients

The drug ERIKA contains a combination of these active pharmaceutical ingredients (APIs):

1 Calcium carbonate
UNII H0G9379FGK - CALCIUM CARBONATE

Calcium carbonate releases, in a pH-dependent manner, calcium ions in the stomach. Calcium carbonate is widely used as antacid and extensively used as a dietary supplement.

Read about Calcium carbonate
2 Magnesium carbonate
UNII 0E53J927NA - MAGNESIUM CARBONATE

Magnesium carbonate, MgCO3 (archaic name magnesia alba), is an inorganic salt. The most common magnesium carbonate forms are the anhydrous salt called magnesite (MgCO3) and the di, tri, and pentahydrates known as barringtonite (MgCO3·2 H2O), nesquehonite (MgCO3·3 H2O), and lansfordite (MgCO3·5 H2O), respectively. The primary use of magnesium carbonate is the production of magnesium oxide by calcining.

Read about Magnesium carbonate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A02AD Combinations and complexes of aluminium, calcium and magnesium compounds A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02A Antacids
Discover more medicines within A02AD

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 1089-MEN-0617

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.